Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Prostate Cancer
Roswell Park Awarded $7.5 million for Prostate Cancer Research
October 8th, 2007
The National Cancer Institute has awarded a five-year, $7.5 million Program Project Grant to Roswell Park Cancer Institute (RPCI) for translational research on the prevention of prostate cancer. Clement Ip, PhD, Distinguished Member and Head of Cancer Chemoprevention at RPCI, is the principal investigator. The ultimate goal of the funded research is to develop a novel strategy to manage the disease at an early stage to prevent it from becoming clinically relevant. Toward that end, researchers will pursue three highly integrated projects based on suppressing androgen signal transduction – a key element in the development of prostate cancer – at two different steps...
Source: Biotech Business Week (2007-10-08)
|
